Name
Perearst Meelis Kaup OÜ
Registry code
14378417
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.11.2017 (6)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment
416 676 €
83 826 €
20%
2 874 €
(estimate is approximate)
139 649 €
3
Submitted
No tax arrears
60%
46%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Meelis Kaup 28.05.1956 (68) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Räpina Tervisekeskus 14708866 | 20% - 500.00 EUR | - | - | Founder |
| 2019 22.04.2020 | 2020 08.04.2021 | 2021 21.04.2022 | 2022 20.04.2023 | 2023 12.03.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 237 974 € | 294 873 € | 331 816 € | 370 260 € | 416 676 € |
| Net profit (loss) for the period | 29 580 € | 57 294 € | 53 422 € | 60 183 € | 83 826 € |
| Profit Margin | 12% | 19% | 16% | 16% | 20% |
| Current Assets | 83 295 € | 102 237 € | 119 397 € | 132 771 € | 171 661 € |
| Fixed Assets | 19 917 € | 18 806 € | 15 492 € | 12 442 € | 9 795 € |
| Total Assets | 103 212 € | 121 043 € | 134 889 € | 145 213 € | 181 456 € |
| Current Liabilities | 28 289 € | 33 826 € | 39 250 € | 39 390 € | 41 807 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 74 923 € | 87 217 € | 95 639 € | 105 823 € | 139 649 € |
| Employees | 3 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 27 844.89 € | 20 133.75 € | 3 |
| 2023 Q4 | - | 11 903.28 € | 12 342.63 € | 3 |
| 2023 Q3 | - | 15 868.53 € | 16 507.09 € | 3 |
| 2023 Q2 | - | 11 515.23 € | 11 908.6 € | 3 |
| 2023 Q1 | - | 25 725.43 € | 17 670.35 € | 4 |
| 2022 Q4 | - | 10 578.4 € | 10 898.37 € | 4 |
| 2022 Q3 | - | 16 280.55 € | 16 970.32 € | 3 |
| 2022 Q2 | - | 9 845.31 € | 10 126.29 € | 3 |
| 2022 Q1 | - | 30 028.65 € | 22 285.93 € | 3 |
| 2021 Q4 | - | 10 124.47 € | 10 424.72 € | 3 |
| 2021 Q3 | - | 14 210.21 € | 14 778.14 € | 3 |
| 2021 Q2 | - | 9 442.35 € | 9 705 € | 3 |
| 2021 Q1 | - | 21 781.32 € | 12 189.65 € | 3 |
| 2020 Q4 | - | 9 666.22 € | 9 946.31 € | 4 |
| 2020 Q3 | - | 11 166.21 € | 11 540.54 € | 4 |
| 2020 Q2 | - | 8 908.78 € | 9 123.41 € | 3 |
| 2020 Q1 | - | 20 667.87 € | 9 802.92 € | 3 |
